Trial Information
Preoperative Embolization in Surgical Treatment of Spinal Metastases. A Randomized Controlled Trial.
Inclusion Criteria:
- Patients scheduled for decompression and posterior thoracic and/or lumbar
instrumented spinal fusion because of spinal metastasis/metastases.
- Informed signed consent.
Exclusion Criteria:
- Contrast fluid allergy.
- Clotting disorders.
- Renal failure.
- Not suitable for arterial access.
- Pregnancy.
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Treatment
Outcome Measure:
Perioperative blood loss
Outcome Time Frame:
Measured intraoperatively and 24 hours postoperatively.
Safety Issue:
No
Principal Investigator
Lars Lönn, MD, Ph.d.
Investigator Role:
Study Chair
Investigator Affiliation:
Department of Radiology, Rigshospitalet. Copenhagen, Denmark.
Authority:
Denmark: The Danish National Committee on Biomedical Research Ethics
Study ID:
H-2-2011-024
NCT ID:
NCT01365715
Start Date:
May 2011
Completion Date:
January 2014
Related Keywords:
- Spinal Metastases
- Preoperative embolization
- Transcatheter arterial embolization
- Therapeutic angiography
- Embolization
- Surgical blood loss
- Spinal metastases
- Spinal neoplasms
- Vertebral metastases
- metastatic spine surgery
- Spinal surgery
- Neoplasm Metastasis
- Neoplasms, Second Primary